Henry Schein to acquire majority stake in Biotech Dental

Henry Schein announced a definitive agreement to acquire a majority ownership stake in Biotech Dental, a French provider of clinical software and oral surgery and orthodontic products. The transaction is subject to regulatory approvals; deal value not disclosed.

“Henry Schein and Biotech Dental are committed to offering customers best-in-class, user-friendly, customer-centric solutions based on open architecture that help improve patient outcomes.”businesswire.com

• 2 sources
• businesswire.comHenry Schein Makes Investment to Form Strategic Partnership With Biotech Dental GroupInvestorsDec 16, 2022
• information-dentaire.frHenry Schein va acquérir une participation majoritaire dans Biotech Dental – L'Information DentaireFontenelle nicolasDec 20, 2022

Summarized from public sources; check the original articles before acting on it.